Beth Israel Deaconess - Revenue projection

  1. 330 Posts.
    lightbulb Created with Sketch. 48
    With the introduction of the new annual subscription agreement fee (ASAF) model in the recent investor webinar, I put together some figures for the first major customer, Beth Israel Deaconess Medical Center (BIDMC). This is my interpretation only, please let me know if your figures differ or you identify mistakes.

    Some notes:
    • Although BIDMC is fully integrated, it is not yet a paying customer due to a contra agreement (use of Echosolv in exchange for services related to the health outcomes study). As a result, I don’t expect any cash flow in the March quarter. The June quarter may see a small amount, but with the 90-day free trials in place, it’s unlikely. The first revenue should appear in the September quarter, either from the misc code or potentially the Cat 3 code if approved. Would be happy to be proven wrong on these points.
    • The previously advised split of the reimbursement between EIQ/customer appears to now be void. Use of the software will be free to the customer as reimbursement covers the cost. For the customer to make money on the use of the software the onus is on them to improve the average approval rate of reimbursement thereby generating excess reimbursement revenue above EIQ's ASAF which they will keep.
    • I've used the top end of the AS reimbursement being $150 USD though this can vary.
    • I've used the total Echos per year performed by BIDMC though this may not be accurate as I'm not certain if they would all relate to AS.

    MISC CODE
    1BIDMC Echos per year30,000.00
    2AS reimbursement$150.00
    3Misc code avg reimbursement approval30.00%
    4Number of Echos potentially approved for reimbursement9,000.00
    5EIQ annual subscription agreement fee$1,350,000.00
    6EIQ monthly fee$112,500.00
    7

    8CAT 3 CODE
    9BIDMC Echos per year30,000.00
    10AS reimbursement$150.00
    11Cat 3 code avg reimbursement approval50.00%
    12Number of Echos potentially approved for reimbursement15,000.00
    13EIQ annual subscription agreement fee$2,250,000.00
    14EIQ monthly fee$187,500.00
    15

    16CAT 1 CODE
    17BIDMC Echos per year30,000.00
    18AS reimbursement$150.00
    19Cat 1 code avg reimbursement approval90.00%
    20Number of Echos potentially approved for reimbursement27,000.00
    21EIQ annual subscription agreement fee$4,050,000.00
    22EIQ monthly fee$337,500.00


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
23.0¢
Change
0.000(0.00%)
Mkt cap ! $148.3M
Open High Low Value Volume
23.0¢ 23.5¢ 23.0¢ $139.8K 606.3K

Buyers (Bids)

No. Vol. Price($)
2 772241 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 176250 4
View Market Depth
Last trade - 16.10pm 22/07/2025 (20 minute delay) ?
EIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.